logo
Sparta Rotterdam complete important deal keeping loanee at Het Kasteel

Sparta Rotterdam complete important deal keeping loanee at Het Kasteel

Yahoo03-06-2025
As per VoetbalPrimeur, Sparta Rotterdam have made a major move on the transfer market, making Nökkvi Thórisson's loan move permanent. The Rotterdammers have officially exercised the purchase option from the initial loan agreement with St. Louis City in the winter window.
The Icelandic Thórisson has signed a contract with Sparta until mid-2028. It is not clear how much the club have paid for the 25-year-old striker. What is clear, however, is that technical director Gerard Nijkamp ​​is very happy with the move.
Advertisement
'In the past six months, Nökkvi's loan spell has been very good for both us and him. In the conversations we had, it quickly became clear that he was happy at Sparta and that we both wanted to continue working together for a longer period of time.'
Thórisson played twelve Eredivisie matches for Sparta in recent months, scoring two goals in the process. The forward is one of the many players who played on loan under coach Maurice Steijn this season.
While Thórisson stays, Carel Eiting, Kristian Hlynsson, Gjivai Zechiël and Mitchell van Bergen will all return to their parent clubs.
GBeNeFN | Max Bradfield
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Kerecis to Showcase Fish-Tissue Derived Tendon Protection Surgical Graft at APMA 2025
Kerecis to Showcase Fish-Tissue Derived Tendon Protection Surgical Graft at APMA 2025

Business Wire

time23-07-2025

  • Business Wire

Kerecis to Showcase Fish-Tissue Derived Tendon Protection Surgical Graft at APMA 2025

ARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)--Kerecis, the company pioneering the use of fish-tissue in cellular therapy and tissue regeneration, will debut its latest innovation, SurgiBind® Tendon Protect, at the American Podiatric Medical Association's (APMA) Annual Scientific Meeting in Grapevine, Texas, July 24-27, 2025. The new biologic graft is designed for tendon procedures where no significant tissue loss is present and will be spotlighted during educational and interactive sessions throughout the conference. 'SurgiBind® Tendon Protect was developed in response to a need consistently identified by surgeons. Namely, coverage for repaired tendons that is straightforward to use and compatible with surgical workflows,' said Fertram Sigurjonsson, Founder and CEO of Share APMA 2025 As part of its presence at APMA 2025, Kerecis will exhibit at Booth #805 and host a clinical education event, 'Taste of Iceland,' on Friday, July 25, from 7:00 to 9:00 PM at Mission Plaza, Gaylord Texan Resort. During the session, Dr. James Cottom, DPM, will present 'Gliding into Enhanced Tendon Outcomes with Intact Fish Skin,' a talk exploring the clinical use of SurgiBind® Tendon Protect in tendon repair procedures. Attendees will also have the opportunity to learn more about the broader application of intact fish-tissue grafts while sampling traditional Icelandic cuisine. Designed for Tendon Protection and Surgical Efficiency Each year, an estimated 500,000 tendon procedures are performed in the United States, many of which aim to preserve or restore movement following tendon injury. SurgiBind® Tendon Protect is intended to be wrapped around a repaired tendon during surgery and is cleared for implantation to reinforce soft tissue where weakness exists. The product is a solid, intact fish-tissue based graft, sustainably sourced from North Atlantic cod, and is bioresorbable, non-crosslinked, and designed to be sutured and positioned with ease in the surgical field. 'Tendon Protect was developed in response to a need consistently identified by surgeons. Namely, coverage for repaired tendons that is straightforward to use and compatible with surgical workflows,' said Fertram Sigurjonsson, Founder and CEO of Kerecis. 'The result is a graft that is structurally sound and easy to handle, offering an alternative to mammalian-derived products.' Clinical Use SurgiBind® Tendon Protect is intended for use in ambulatory surgical centers (ASCs) and hospital outpatient departments (HOPDs), providing a physical covering around repaired tendons where there is no significant tissue loss. Its strength and pliability support secure placement and suture fixation and reduces the risk of readmissions or revision procedures related to scarring or adhesion, factors that can increase overall treatment costs and affect reimbursement. Audit-Ready™ To support providers, Kerecis offers coding and reimbursement guidance through its Audit-Ready™ program, designed to align with U.S. payor requirements, reduce administrative burden, and streamline claims and documentation. Available Nationwide SurgiBind® Tendon Protect marks the continued expansion of the Kerecis SurgiBind® portfolio, which now includes options for general surgical, trauma, and tendon-related procedures. The product is currently available across the United States through Kerecis' direct sales force. About Kerecis Kerecis, founded by Fertram Sigurjonsson, develops intact fish tissue derived products for cellular therapy, tissue regeneration, and protection. When grafted onto damaged human tissue or implanted, the patented material supports the body's own processes to heal and regenerate. Because no disease-transfer risk exists between cold-water fish and humans, Kerecis products are only gently processed and retain their similarity to human tissue. The gentle processing preserves the material's original three-dimensional structure, maintaining its inherent natural strength, complexity, and molecules (such as fatty acids). Clinical studies show that Kerecis products heal wounds faster than competitors. Kerecis is the only global manufacturer of medical devices containing intact fish-tissue and is the fastest growing company in the U.S. xenograft biologics skin market. Products include SurgiBind®/SurgiClose®, GraftGuide®, MariGen®, and Shield™ for various medical applications. Committed to the UN Sustainable Development Goals, Kerecis uses sustainably sourced Icelandic fish processed with renewable energy. Kerecis is a part of Coloplast, a leading supplier of intimate healthcare products. For more information about Kerecis and its clinical research, visit Trademarks and registered trademarks are the property of their respective owners.

Angel City welcomes infusion of talent with hope of netting more wins
Angel City welcomes infusion of talent with hope of netting more wins

Los Angeles Times

time23-07-2025

  • Los Angeles Times

Angel City welcomes infusion of talent with hope of netting more wins

Ever since she visited Los Angeles with her national team three years ago, Sveindís Jane Jónsdóttir knew she wanted to play in the National Women's Soccer League one day. When the opportunity to play for Angel City presented itself, Jónsdóttir was eager to join the league and play for new Angel City coach Alexander Straus. 'When Angel City came up, I was just really excited about it,' she said. 'I know Alex. I played against him when he was at Bayern and so I knew he was a great coach.' Three new players have joined Angel City (4-3-6) during the past few months, delivering an infusion talent for a team that sits in 11th place in the 14-team NWSL standings. The league's top eight teams advance to the playoffs. Jónsdóttir, a forward with Icelandic national team experience, signed with Angel City on May 21. After finishing her stint with Frauen-Bundesliga club VfL Wolfsburg, Jónsdóttir joined her first Angel City practice on Tuesday afternoon. Midfielder Evelyn Shores, who most recently played for the University of North Carolina, signed with Angel City on July 10. She has played for the U-23 U.S. women's national team. Goalkeeper Hannah Seabert, who was Sporting Clube de Portugal's captain earlier this year, signed with Angel City on May 30 and has been training with the team for three weeks. Seabert, a Riverside native and Pepperdine alum, spent most of her career playing abroad and wanted to return to the United States. 'As soon as Angel City opened up several years back, I just knew it was a team I wanted to be a part of,' she said of the franchise that began play in 2023. When Seabert's contract with Sporting CP expired, she pursued her goal of joining Angel City. 'When I came and visited here a couple weeks ago, it felt like a home away from home,' she said. 'The facilities are amazing and the girls were so welcoming. It just felt right when I came here.' Angel City sporting director Mark Parsons said the new players earned contracts because they aligned with the vision for the future of the club: winning. 'Who are the players that we believe represent where we're going and can play for Angel City when we're fighting for trophies,' Parsons said, referring to the question Angel City leaders asked before signing any new players. While the new players present an infusion of fresh talent, Angel City also is benefiting from the return of a familiar face. Forward Jun Endo, who tore her ACL in February 2024, played for the first time in 18 months during a friendly against Bay FC on Saturday. Endo was on the pitch for 30 minutes and scored the only goal of the game. 'If you're missing a player like Jun Endo for as much time as Angel City has been missing her, of course it affects [the game] because you cannot replace a player like that,' said Straus, the team's coach. Straus said he expects Angel City to evolve and move closer to achieving its long-term championship goals with the new signees and Endo available to play. Angel City, which is in the midst of an international break, plays a friendly Saturday against Carolina Ascent FC and resumes NWSL competition on Aug. 1 at Seattle Reign FC. 'Its not just about filling a roster,' Straus said. 'We need quality. We need people who can make a difference for us and so we hope they will do this for us. 'We will be good now, but we will be better in January.'

Stoke City are working hard to sign Mamadou Lamine Camara
Stoke City are working hard to sign Mamadou Lamine Camara

Yahoo

time23-07-2025

  • Yahoo

Stoke City are working hard to sign Mamadou Lamine Camara

The Senegalese seems to be on the cusp of a new experience in his professional career. Stoke City are working hard to sign Mamadou Lamine Camara After many years spent with Renaissance Sportive de Berkane in Morocco and North Africa, the Icelandic defensive midfielder looks set for a new experience in England with one of the country's leading clubs, Stoke City, and press reports indicate that the player is currently in England to finalise his move and undergo the necessary medical examinations. Significant interest from several top European clubs Interest in the 22-year-old is not limited to Stoke City, with Crystal Palace, Fenerbahçe, Atletico Madrid and Villarreal in Spain also interested in the player. However, recent press reports suggest that Stoke City are the club that ultimately prevailed in the race for the player's services, despite the many and varied financial offers that were made. According to our sources, a preliminary agreement has been reached between Stoke City and RS Berkane, pending the completion of the deal after the player undergoes medical tests. The Moroccan club hopes to recover between €4 and €5 million for a player currently valued at €1.4 million on Transfermarkt. The young Senegalese talent, who shone this season with Berkane and impressed with the U-23 national team of Les Lions de la Téranga, is on the verge of a major career milestone. A potential move to England could mark a significant step forward in his journey toward the pinnacle of European football.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store